Robert Half
RHI
$37.85
-7.00%
Robert Half Inc. is a specialized staffing and consulting firm providing temporary, permanent, and outcome-based talent solutions in finance, technology, legal, marketing, and administrative fields, along with consulting services through its Protiviti subsidiary. As one of the largest specialized staffing firms in the fragmented U.S. market, it holds a strong brand and established client relationships. The current investor narrative centers on a sharp recovery in demand for staffing services, as evidenced by a significant stock price rally in recent months, while the company navigates a cyclical downturn in revenue and profitability. Recent news highlights a consistent dividend payout, underscoring financial stability and income appeal.…
RHI
Robert Half
$37.85
Related headlines
Investment Opinion: Should I buy RHI Today?
Rating: Hold. The thesis is that RHI offers a high dividend yield and a strong balance sheet, but the stock's recent rally has outpaced fundamental improvement, and analyst consensus points to significant downside. The average analyst target of $30.78 implies 26.4% downside, and the consensus is 'hold' with a mean score of 3.09. Supporting evidence: (1) Trailing PE of 20.4x is above the industry median of ~15x, suggesting a premium that may not be justified. (2) Revenue declined 3.8% YoY in Q1 2026, and net income dropped 20.6%. (3) Free cash flow turned negative to -$120.8M in Q1 2026. (4) The dividend yield of 8.76% is attractive but the payout ratio of 179% is unsustainable. Risks: The biggest risks are (1) a prolonged downturn in staffing demand causing further revenue and earnings declines, (2) a dividend cut if cash flow does not improve, and (3) multiple compression if the recovery fails to materialize. This Hold would upgrade to Buy if revenue growth turns positive and free cash flow improves, or downgrade to Sell if the dividend is cut or earnings deteriorate further. Valuation verdict: The stock appears overvalued relative to its fundamentals and analyst targets, but the high dividend yield provides some support.
Sign up to view all
RHI 12-Month Price Forecast
The AI assessment is bearish with medium confidence. While the stock has strong momentum and a high dividend yield, the fundamental picture remains weak with declining revenue, negative free cash flow, and a premium valuation. The analyst consensus is cautious, and the average target suggests significant downside. The key risk is that the recent rally has disconnected from fundamentals, and a correction is likely if the recovery does not materialize. An upgrade to neutral would require evidence of revenue stabilization and positive free cash flow.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Robert Half's 12-month outlook, with a consensus price target around $30.78 and implied upside of -18.7% versus the current price.
Average Target
$30.78
0 analysts
Implied Upside
-18.7%
vs. current price
Analyst Count
—
covering this stock
Price Range
$20 - $50
Analyst target range
The stock is covered by 9 analysts, with a consensus recommendation of 'hold' and a mean recommendation score of 3.09 (where 1=Strong Buy, 5=Strong Sell). The average target price is $30.78, implying a downside of 26.4% from the current price of $41.80. The distribution shows 1 Buy (Truist Securities), 2 Outperform (William Blair), 3 Hold (Barclays, BMO, JP Morgan), and 1 Sell (Goldman Sachs), with the rest neutral. The consensus is cautious, reflecting the disconnect between the stock's rally and still-weak fundamentals. The target range spans from a low of $20.00 to a high of $50.00. The high target of $50 assumes a successful cyclical recovery with margin expansion and revenue growth, while the low target of $20 implies a prolonged downturn or further deterioration. The wide spread ($20-$50) indicates high uncertainty. Recent ratings actions include a downgrade to Sell by Goldman Sachs (maintained) and an upgrade to Outperform by William Blair in April 2026, suggesting mixed sentiment. The lack of strong bullish consensus suggests the recent rally may be ahead of fundamentals.
Bulls vs Bears: RHI Investment Factors
RHI presents a classic cyclical turnaround debate. The bull case rests on a strong balance sheet, low debt, a high dividend yield, and a recent price surge that anticipates a recovery in staffing demand. The bear case highlights continued revenue and earnings declines, negative free cash flow, and a consensus analyst target implying 26% downside. The single most important tension is whether the recent rally is justified by an impending cyclical recovery or is overextended relative to still-weak fundamentals. Currently, the bearish evidence from fundamentals and analyst sentiment appears stronger, but the bullish momentum cannot be ignored.
Bullish
- Strong Recent Momentum: The stock has rallied 52.3% over the past 3 months and 29.6% over the past month, far outpacing the S&P 500's 4.67% and 0.31% gains, respectively. This suggests the market is pricing in a cyclical recovery in staffing demand.
- Low Debt and Solid Liquidity: Debt-to-equity is only 0.33 and the current ratio is 1.52, indicating a strong balance sheet. The company has ample liquidity to weather the downturn and fund operations.
- Attractive Dividend Yield: With a dividend yield of 8.76% and a consistent payout history, RHI offers a compelling income component. The recent dividend announcement reinforces financial stability.
- Valuation Near Historical Lows: The trailing PE of 20.4x is near the lower end of its five-year range (11.6x to 80.2x). The PB ratio of 2.13x is well below the historical average of ~5x, suggesting potential upside if earnings recover.
Bearish
- Revenue and Earnings Declining: Q1 2026 revenue fell 3.8% YoY to $1.30B, and net income dropped 20.6% to $13.8M. Operating margin compressed to 2.8% from 2.9% a year ago, reflecting ongoing cyclical headwinds.
- Negative Free Cash Flow in Q1: Free cash flow turned negative to -$120.8M in Q1 2026, compared to positive $104.2M in Q2 2025. This deterioration raises concerns about working capital management and cash generation.
- Analyst Consensus is Hold with Downside: The average analyst target is $30.78, implying 26.4% downside from the current price of $41.80. The consensus rating is 'hold' with a mean score of 3.09, indicating cautious sentiment.
- Stock Near 52-Week High, Overextended: At $41.80, the stock is at 96.6% of its 52-week range ($21.83-$43.26). The rapid rally may have priced in a recovery that has not yet materialized in earnings, increasing pullback risk.
RHI Technical Analysis
The stock is in a strong recovery uptrend, with a 1-year price change of -0.83% masking a dramatic rebound from its 52-week low of $21.83. Currently trading at $41.80, the stock is at 96.6% of its 52-week range ($21.83-$43.26), indicating it is near the highs and reflecting robust momentum. This positioning suggests the market is pricing in a cyclical recovery, though it also raises the risk of overextension in the near term. Short-term momentum is exceptionally strong, with a 1-month price change of +29.6% and a 3-month change of +52.3%, far outpacing the S&P 500's 1-month and 3-month gains of 0.31% and 4.67%, respectively. This acceleration from the longer-term trend signals a potential trend reversal from the prior downtrend, supported by a relative strength index (RSI) implied by the rapid gains. The divergence between the 1-year decline and the recent surge suggests a fundamental shift in sentiment, likely driven by improving labor market data or company-specific catalysts. Key resistance lies at the 52-week high of $43.26, a breakout above which would confirm a new uptrend and target higher levels. Support is at the 52-week low of $21.83, though the stock is far from that level. With a beta of 0.809, the stock is less volatile than the broader market, meaning its recent 52.3% 3-month gain is particularly noteworthy and implies strong company-specific momentum. A pullback to the $30-$32 area (recent consolidation zone) would be a healthy retracement.
Beta
0.81
0.81x market volatility
Max Drawdown
-49.2%
Largest decline past year
52-Week Range
$22-$43
Price range past year
Annual Return
-10.7%
Cumulative gain past year
| Period | RHI Return | S&P 500 |
|---|---|---|
| 1m | +29.0% | +0.6% |
| 3m | +47.8% | +3.4% |
| 6m | +32.5% | +7.1% |
| 1y | -10.7% | +16.4% |
| ytd | +38.4% | +8.3% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
RHI Fundamental Analysis
Revenue has been declining, with the most recent quarter (Q1 2026) reporting $1.300 billion, down 3.8% year-over-year from $1.352 billion in Q1 2025. This marks a continuation of a multi-quarter deceleration, as revenue peaked at $1.472 billion in Q2 2024 and has since trended lower. The decline is broad-based, with Contract Talent Solutions ($539 million) and Permanent Placement Staffing ($109 million) both facing headwinds from a soft labor market. The investment case hinges on a cyclical recovery; if the recent stock rally anticipates a rebound, revenue growth must resume. Profitability has compressed significantly. Net income in Q1 2026 was $13.8 million, down from $17.4 million in Q1 2025, and gross margin slipped to 36.9% from 37.2% a year ago. Operating margin fell to 2.8% from 2.9%, and net margin dropped to 1.1% from 1.3%. The company remains profitable, but margins are near cyclical lows. For context, operating margin was 16.4% in Q2 2022, highlighting the severity of the downturn. The balance sheet is solid but showing strain. Debt-to-equity is low at 0.33, and the current ratio of 1.52 indicates adequate liquidity. However, free cash flow turned negative in Q1 2026 at -$120.8 million, compared to positive $104.2 million in Q2 2025, driven by working capital outflows. The TTM free cash flow of $217.7 million still provides a cushion, but the negative quarterly FCF bears watching. ROE of 10.4% is respectable but down from historical levels above 20%.
Quarterly Revenue
$1.3B
2026-03
Revenue YoY Growth
-3.8%
YoY Comparison
Gross Margin
36.9%
Latest Quarter
Free Cash Flow
$217717000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is RHI Overvalued?
Since net income is positive ($13.8 million), the PE ratio is the primary valuation metric. The trailing PE is 20.4x, while the forward PE is 20.3x, implying the market expects earnings to remain flat. The narrow gap suggests limited growth expectations, which contrasts with the recent stock surge. Compared to the industry average (Staffing & Employment Services), the stock trades at a premium. The trailing PE of 20.4x is above the sector median of approximately 15x, representing a 36% premium. This premium may be justified by Robert Half's strong brand and market position, but it also prices in a recovery that has not yet materialized in earnings. Historically, the stock's PE has ranged from 11.6x (Q2 2022) to 80.2x (Q1 2025). The current 20.4x is near the lower end of its five-year range, suggesting the market is not pricing in overly optimistic expectations. However, the recent price surge has lifted the PE from single-digit levels earlier in 2026, indicating a rapid re-rating. The PB ratio of 2.13x is well below the historical average of ~5x, reflecting the decline in book value multiple.
PE
20.4x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 12x~33x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
11.0x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: RHI's revenue has declined for four consecutive quarters, with Q1 2026 down 3.8% YoY. Net income fell 20.6% to $13.8M, and operating margin compressed to 2.8% from 2.9%. Free cash flow turned negative to -$120.8M in Q1 2026, a sharp reversal from positive $104.2M in Q2 2025. The dividend payout ratio of 179% indicates the dividend is not fully covered by earnings, posing a risk of reduction if earnings do not recover. Market & Competitive Risks: The stock trades at a trailing PE of 20.4x, a 36% premium to the industry median of ~15x, leaving it vulnerable to multiple compression if the recovery disappoints. With a beta of 0.809, it is less volatile than the market, but the recent 52.3% three-month gain is company-specific and could reverse. The fragmented staffing industry faces competitive pressure, and a prolonged soft labor market could delay recovery. Worst-Case Scenario: If the economy enters a recession and staffing demand continues to weaken, revenue could decline further, margins could compress below current levels, and the stock could fall to its 52-week low of $21.83, representing a 47.8% loss from the current price of $41.80. This scenario aligns with the analyst low target of $20.00.
FAQ
The key risks are: (1) Financial risk: Negative free cash flow of -$120.8M in Q1 2026 and a dividend payout ratio of 179% could lead to a dividend cut. (2) Competitive risk: The staffing industry is fragmented and competitive; a prolonged soft labor market could delay recovery. (3) Macro risk: A recession would further reduce demand for staffing services, potentially driving the stock to its 52-week low of $21.83 (47.8% downside). (4) Valuation risk: The stock trades at a premium PE of 20.4x versus the industry median of 15x, leaving it vulnerable to multiple compression. The most severe risk is a dividend cut, which would likely cause a sharp sell-off.
The 12-month outlook is uncertain with three scenarios. The base case (50% probability) sees the stock trading near the analyst average target of $30.78, implying 26.4% downside, as revenue stabilizes but does not grow. The bull case (20% probability) targets $43.26 to $50.00 if a strong economic recovery boosts staffing demand. The bear case (30% probability) sees the stock falling to $20.00-$21.83 if a recession hits. The most likely scenario is the base case, given the still-weak fundamentals and cautious analyst sentiment. The key assumption is that the labor market will improve modestly but not dramatically.
RHI's trailing PE of 20.4x is above the industry median of approximately 15x, indicating a 36% premium. The PB ratio of 2.13x is well below the historical average of ~5x, but this reflects the decline in book value multiple. The forward PE of 20.3x implies the market expects flat earnings, which contrasts with the recent stock surge. Compared to its own history, the current PE is near the lower end of its five-year range (11.6x to 80.2x), suggesting it is not extremely overvalued. However, given the declining earnings, the stock appears overvalued relative to its fundamentals and analyst targets. The market is pricing in a recovery that has not yet materialized.
RHI offers a high dividend yield of 8.76% and has a strong balance sheet with low debt, but the stock is in a cyclical downturn with declining revenue and earnings. The analyst consensus is 'hold' with an average target of $30.78, implying 26.4% downside from the current price of $41.80. For income investors with a long-term horizon and tolerance for volatility, the dividend may be attractive, but the risk of a dividend cut is real given the payout ratio of 179%. For capital appreciation, the stock appears overvalued relative to fundamentals. It may be a good buy only if you believe a strong cyclical recovery is imminent and are willing to accept the risk of near-term losses.
RHI is more suitable for long-term investment, particularly for income-oriented investors who can hold through the cycle. The stock has a beta of 0.809, indicating lower volatility than the market, but its cyclical nature means it can experience significant drawdowns (max drawdown -50.08%). The high dividend yield of 8.76% provides a return cushion for long-term holders. Short-term trading is risky given the stock's recent 52.3% rally and proximity to its 52-week high, which increases the chance of a pullback. A minimum holding period of 3-5 years is recommended to allow for a cyclical recovery and to benefit from dividend compounding.